25/04/2025 - General information
Dr. Anna Bigas, coordinator of the Stem Cells and Cancer Research Group at the Hospital del Mar Research Institute, has been appointed Visiting Professor at Åbo Akademi University in Turku, Finland. Her appointment aims to strengthen the InFLAMES project, a joint initiative between Åbo Akademi and the University of Turku. Dr. Bigas focuses part of her research on generating blood stem cells in the lab, as well as understanding chemotherapy resistance mechanisms in acute leukemias. With her incorporation into Åbo Akademi University, the institution seeks to boost its research capabilities in the field of hematopoietic stem cells and blood-related disorders.
Més informació "Finnish Åbo Akademi University appoints Dr. Anna Bigas as Visiting Professor"
22/04/2025 - Covid-19
A study led by the Hospital del Mar Research Institute, in collaboration with the Caldes de Montbui City Council, has validated the use of thermal waters to reduce some symptoms in people affected by long COVID. Balneotherapy helped improve pain and fatigue, with benefits that persisted after treatment ended. Improvements were also observed in sleep quality and anxiety, although these did not last over time. People with long COVID who underwent a one-month thermal water treatment program were twice as likely to improve their symptoms compared to those who did not receive the treatment.
Més informació "Balneotherapy Improves Various Symptoms of Long COVID"
15/04/2025 - Press release
A study by researchers from the Hospital del Mar Research Institute, IIBB-CSIC-IDIBAPS, Mayo Clinic, IBYME (CONICET), and CaixaResearch Institute demonstrates the role of the Galectin-1 protein in the nucleus of the cells surrounding the tumor-fibroblasts-contributing to their activation. Activated fibroblasts promote tumor growth and spread, while also conferring resistance to treatments. This may be one of the reasons behind the high aggressiveness of pancreatic cancer, which has a five-year survival rate of only 10%. The study's findings open the door to new therapeutic strategies against this type of cancer, focusing on the possibility of inhibiting this protein within the cells that surround and protect the tumor.
Més informació "Key to the high aggressiveness of pancreatic cancer identified"
11/04/25 - Institutional news
Dr. Jenniffer Linares, a researcher with the Colorectal Cancer Precision Medicine Research Group at the Hospital del Mar Research Institute, has received the CRIS Program for Translational Medical Talent, awarded by the CRIS Against Cancer Foundation. A total of 11 million euros in funding has been granted through the CRIS Research Programs 2024, with the aim of promoting cancer research that places the patient at the center of scientific advancement. The awarded project, "Uncovering the Clinical Impact of Stromal-Derived Mechanisms of Resistance to Anti-EGFR Therapy in Colorectal Cancer," seeks to understand the mechanisms of resistance to anti-EGFR therapies derived from the tumor microenvironment in patients with RAS wild-type metastatic colorectal cancer. The goal is to identify predictive markers and develop new therapeutic strategies to overcome these mechanisms. The project will receive funding of 400,000 euros.
Més informació "CRIS Against Cancer Awards Dr. Jenniffer Linares"
10/04/2025 - Institutional news
This initiative, aimed at supporting people with mild to moderate depression, is being relaunched with new and improved features. The goal is to enhance both user experience and accessibility. The project is an initiative of the European Alliance Against Depression (EAAD), in collaboration with the Mental Health area of CIBER (CIBERSAM), and led by the Hospital del Mar Research Institute in Spain.
09/04/2025 - Press release
A study involving more than 1,700 people from five hospitals in Barcelona, Sweden and Italy has validated the usefulness of a biomarker in blood to detect Alzheimer's disease in the clinical setting. The study, published in the journal Nature Medicine, demonstrates that this test can be a useful and applicable tool in routine medical practice. The automated analysis of this biomarker is more than 90% effective in identifying patients with Alzheimer's disease. It is an easy-to-use tool that can partly replace other, more complex diagnostic tests, such as lumbar puncture or positron emission tomography (PET). The study has established cut-off points from which the patient's symptoms can be considered to be caused by Alzheimer's, if Alzheimer's disease can be ruled out, or if further tests are needed to determine the cause of the disease.
Més informació "A blood test for early detection of Alzheimer's disease"
04/04/25 - Institutional news
The Scientific Foundation of the Spanish Association Against Cancer has just named the accredited centres under the AECC Scientific Foundation Accreditation 2024, among them, the Hospital del Mar Research Institute. In total, there are 13 centres of excellence in cancer research that receive this recognition. With this initiative, the Scientific Foundation aims to promote coordination and collaboration between the centres and the organisation, as well as achieve more efficient management of funds and maximise their impact. To adhere to the accreditation, the research institute had to undergo a thorough evaluation process, in which it was verified that it meets the requirements to join the accreditation. In this regard, it was certified that the institute has at least two active project grants awarded by the AECC in the last three years. Also, to have three principal investigators in cancer research, have an ongoing international cancer project or have published two articles in this field as last authors in a high-impact peer-reviewed journal. Finally, to have a defined cancer research strategy with specific lines and periodic action plans.
31/03/25 - General information
People with bronchiectasis, a chronic airway disease characterized by the accumulation of secretions in the bronchi leading to recurrent lung infections, are at high risk of experiencing a decline in muscle mass and function, known as sarcopenia. Having tools to diagnose their condition is vital to slowing its progression and avoiding a point of no return. For this reason, the Muscle Wasting and Cachexia in Chronic Respiratory Diseases and Lung Cancer Research Group of the Hospital del Mar Research Institute, together with the Pneumology and Radiology Services of Hospital del Mar and part of the dibi network, have conducted a study to validate the use of magnetic resonance imaging (MRI) to assess the muscular condition of these patients. The study is published in Archivos de Bronconeumología and also includes researchers from the CIBER Respiratory Diseases area (CIBERES).
27/03/2025 - Press release
Previously unknown access points in cell membrane proteins have been discovered, enabling laboratory-developed drugs to modify cell function. The discovery was made possible through computer simulations with an unprecedented level of detail. The results are available online to support the development of new, targeted drugs for a wide range of diseases. Research centers from thirteen countries collaborated on the study, which has been published in Nature Communications.
Més informació "New pathways discovered for drugs to act on cells"
25/03/2025 - General information
A new study led by researchers from the Hospital del Mar Research Institute and the Barcelonaβeta Brain Research Center (BBRC), the research centre of the Pasqual Maragall Foundation, has made significant strides in the search for effective blood-based biomarkers for Alzheimer's disease early detection. The research, published in the journal Alzheimer's & Dementia, provides a comprehensive comparison of various plasma biomarkers and their accuracy in detecting Alzheimer's disease in a memory clinic setting.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
